Arbutus Biopharma Corp (ABUS)

Sales/Maturities of Investments

$103.11M

TTM · Period ending: · USD

ABUS logo

ABUS Sales/Maturities of Investments

Latest reported$103.11M
ABUS TTM Sales/Maturities of Investments ($2.12M → $103.11M)
High-resolution chart · PNG

ABUS sales/maturities of investments history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Arbutus Biopharma Corp Sales/Maturities of Investments — Trailing twelve months (TTM) (USD)
Period endingSales/Maturities of Investments (USD)
103,112,000
125,212,000
155,277,000
188,134,000
175,203,000
173,518,000
164,639,000
154,195,000
143,371,000
132,456,000
132,270,000
112,026,000
113,500,000
91,000,000
56,000,000
50,000,000
47,000,000
52,000,000
70,350,000
57,200,000
60,800,000
71,780,000
73,398,000
66,548,000
46,948,000
21,968,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-4,538,297
-1
-348,227
2,116,619
6,654,915
2,116,619
2,464,846
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.